Rosmarinic Acid (RA) exhibits anticancer activity by regulating oxidative stress, chronic inflammation, cell cycle, apoptosis, and metastasis. These data suggest that daily use of RA-enriched dietary supplements can contribute to tumor prevention and treatment. RA has the potential for application in anti-tumor drug development.
Exploring novel and experimental combinations of anti-cancer substances to unlock powerful synergies and improve treatment outcomes
Subscribe to:
Posts (Atom)
-
Drug Repurposing in Cancer Treatment Discovering New Uses for Existing Clinically Approved Drugs ...
-
Sodium Phenylbutyrate: Redefining Therapeutic Potential Through Epigenetic Modulation Sodium Phenylbutyrate...
-
Fasting has long been recognized as a natural strategy for enhancing health, with numerous studies demonstrating its benefits for inhibiting...
-
Repurposing non-oncology drugs for cancer treatment has become an area of increasing interest. In particular, combinations of well-known pha...
-
Lung cancer driven by KRAS mutations, particularly the G12C variant, remains a significant challenge in non-small cell lung cancer (NSCLC) t...
No comments:
Post a Comment